Showing 1 posts of 1 posts found.
AstraZeneca and Roche Holding are among a number of drugmakers to cut their prices in order to get on China’s …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO